Spyglass Pharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Spyglass Pharma Inc
TickerSGP
CIK #0001778922
CUSIP85220G109
SectorLife Sciences - Surgical & Medical Instruments & Apparatus
Address27081 Aliso Creek Road Suite 125, Aliso Viejo, CA 92656
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Spyglasspharma Inc 2025-06-05 75.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
Spyglass Ophthalmics Inc 2021-01-05 13.7 M Exemption: 506(b) · Remaining: $23,750,000 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001778922] 10-K
[0001778922] 10-Q
[0001778922] 3
[0001778922] 4
[0001778922] 8-K
[0001778922] D
[0001778922] SC 13D
[0001778922] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Samsara Biocapital LP Spyglass Pharma Inc [2026-02-17] 0.0
RA Capital Management LP Spyglass Pharma Inc [2026-02-17] 0.0
Sands Capital Life Sciences Pulse Fund III de LP Spyglass Pharma Inc [2026-02-13] 0.0
Gilde Healthcare Holding BV Spyglass Pharma Inc [2026-02-13] 0.0
New Enterprise Associates 17 LP Spyglass Pharma Inc [2026-02-13] 0.0
Vensana Capital I GP LLC Spyglass Pharma Inc [2026-02-10] 0.0
Form 3/4/5 Filer 2011 - 2026
SpyGlass Pharma Inc
Chang Carmen
Sandell Scott D
Baskett Forest
Walker Paul Edward
Florence Anthony A Jr
Pardo Geoffrey B
Behbahani Ali
Makhzoumi Mohamad
Khan Bilal Arshad
Mathers Edward T
Yang Rick
Shah Rajeev M
RA Capital Healthcare Fund LP
RA Capital Nexus Fund III LP
RA Capital Management LP
Kolchinsky Peter
NEA 17 GP LLC
New Enterprise Associates 17 LP
NEA Partners 17 LP
Nielsen Kirk G
Vensana Capital Management LLC
Vensana Capital I GP LLC
Klein Peter Justin
Viret Jean-Frederic
Dybbs Michael
Dable Habib J
O'Farrell Elizabeth G
Scheiner Zachary
Kahook Malik Y
Mooney Patrick H
Dennewill James Robert Jr
Pujara Chetan Pratap
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Shah Rajeev M +4
Common Stock
2026-02-09 Buy 248,034 $16.00 3,968,544
Shah Rajeev M +4
Common Stock
2026-02-09 Buy 3,441,966 $16.00 55,071,456
Shah Rajeev M +4
Common Stock
2026-02-09 Conversion 1,806,644
Shah Rajeev M +4
Common Stock
2026-02-09 Conversion 2,524,473
Behbahani Ali
Common Stock
2026-02-09 Conversion 402,273
Behbahani Ali
Common Stock
2026-02-09 Buy 937,500 $16.00 15,000,000
Behbahani Ali
Common Stock
2026-02-09 Conversion 737,962
Behbahani Ali
Common Stock
2026-02-09 Conversion 1,370,168
Behbahani Ali
Common Stock
2026-02-09 Conversion 1,370,168
Behbahani Ali
Common Stock
2026-02-09 Conversion 1,619,240
Behbahani Ali
Common Stock
2026-02-09 Conversion 954,990
Florence Anthony A Jr
Common Stock
2026-02-09 Conversion 1,619,240
Florence Anthony A Jr
Common Stock
2026-02-09 Conversion 402,273
Florence Anthony A Jr
Common Stock
2026-02-09 Conversion 954,990
Florence Anthony A Jr
Common Stock
2026-02-09 Buy 937,500 $16.00 15,000,000
Florence Anthony A Jr
Common Stock
2026-02-09 Conversion 737,962
Florence Anthony A Jr
Common Stock
2026-02-09 Conversion 1,370,168
Florence Anthony A Jr
Common Stock
2026-02-09 Conversion 1,370,168
Baskett Forest
Common Stock
2026-02-09 Conversion 737,962
Baskett Forest
Common Stock
2026-02-09 Buy 937,500 $16.00 15,000,000
showing 20 of 169 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 35 24,654,085
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com